In adults with obesity and/or MAFLD, serum IGF1 levels were lower in those with higher degrees of inflammation and higher stage of fibrosis, and the serum IGF1/IGFBP-3 ratio decreased with increasing fibrosis [36]. Here, IGFBP3 is linked to obesity disorder.